Macarthur Minerals Limited Overview
Macarthur Minerals is a Brisbane-headquartered, ASX-listed iron ore development company. Its single core asset is the 100%-owned Lake Giles Iron Project in Western Australia's Yilgarn region, about 175 km north-west of Kalgoorlie. The project has two parts. The first is the large Moonshine magnetite resource: about 1.27 billion tonnes across all categories, supporting a 2022 Feasibility Study for a 3 Mtpa, 25-year operation producing 66% Fe concentrate. The second is the smaller Ularring hematite resource of about 80 Mt, which is permitted for development. In 2024 Macarthur stopped trying to develop Ularring itself. It sold the hematite mining rights to Gold Valley Yilgarn for A$750,000 cash plus up to A$10M in milestone royalties and a perpetual A$1/dmt royalty. Gold Valley assigned half of that position to mining contractor Destec in 2026. The company is now effectively a royalty-and-optionality vehicle. It has minimal cash, going-concern qualifications, and a magnetite asset that needs a strategic partner able to fund roughly A$863M of initial capital.
Company's own description. The FY2025 Annual Report states that Macarthur "has three iron ore projects in the Yilgarn region of Western Australia" and "two exploration project areas in the Pilbara, Western Australia targeting iron ore." Its principal activity is "mineral resource exploration and evaluation." The risk section is more candid: the group is "at an intermediate stage in its evolution as a Mining Evaluation and Investment company having sold the right to mine its Hematite Project to GVY in 2024," and exploration "is now minimal pending the realisation of the royalty income stream." Standard ASX releases still describe the company as "an iron ore development and lithium exploration company that is focused on bringing to production its Western Australia iron ore projects" (Quarterly Activities Report, 30 July 2026).
Independent characterisation. In practice, Macarthur is a pre-revenue holding company with four economic exposures:
-
A contingent royalty stream. This comes from the Ularring/Treppo Grande hematite rights sold to Gold Valley Yilgarn (GVY), now held 50:50 by GVY and Destec. The royalty pays A$5M after the first 1 Mt dry metric tonnes sold, another A$5M after the second 1 Mt, then A$1/dmt thereafter. Macarthur keeps legal and beneficial title to the tenements.
-
A long-dated, capital-heavy development option. This is the Moonshine magnetite project, which has a completed Feasibility Study but no financing partner.
-
Early-stage exploration optionality. This covers nickel and cobalt at Lake Giles (historical intercepts and seven untested targets), non-iron-ore sampling that has so far been inconclusive, Pilbara iron-ore rights on two Infinity Mining-encumbered tenements, a Treppo Grande/Mount Manning licence application, and a dormant Nevada lithium subsidiary.
-
Infrastructure positioning. This includes miscellaneous licences for haul roads and borefields, an earlier MOU with the Southern Ports Authority for Esperance access, and a dedicated export subsidiary, Esperance Iron Ore Export Company Pty Ltd.
Revenue model. There is currently no product, service, subscription or licensing revenue. Reported "revenue" consists of rental income, interest and sundry recoveries: A$46,578 in FY2025 and about A$13K trailing-twelve-month in FY2026 (Kalkine). The intended future model is a royalty model on hematite, plus a concentrate-sales model on magnetite. The magnetite model would sell 66% Fe concentrate to steelmakers via rail to Esperance. Macarthur previously held a binding life-of-mine offtake agreement with Glencore International, signed in March 2019 and reported at the time of the 2019 ASX IPO. Its current status is not publicly confirmed in 2025–2026 filings.
Value chain position. Upstream: exploration, evaluation and permitting. Macarthur has no mining, processing, logistics or marketing operations. Under the hematite agreement, GVY and Destec carry operating, funding and regulatory responsibility.
Customer types and end-markets. The target customers are integrated steelmakers, mainly in Asia, buying seaborne iron ore. High-grade magnetite concentrate is also positioned for lower-emission steelmaking such as pelletising, direct reduction and "green iron". The company brands itself "the green iron ore company" on its letterhead. There were no customers above 10% of revenue in FY2024 or FY2025 because there is no customer revenue (FY2025 AR, Note 4).
Strategy
Stated strategic themes (FY2025 AR Chairman's Letter; 2026 quarterlies):
-
Unlock near-term revenue from the hematite assets through a third-party operator, using a royalty model in which the operator funds and manages "all operational and regulatory aspects."
-
Keep 100% ownership of the Moonshine magnetite project, the long-term value driver, and secure "strategic transactions that can drive development" through Nigel Jones's network.
-
Keep Lake Giles tenure "in good standing" with minimal cash spend.
-
Simplify the corporate structure and cost base: TSXV/OTC delisting, Infinity divestment, office relocation and auditor change.
-
Position the company within "green iron" narratives by using high-grade magnetite as feed for low-emission steelmaking.
ESG and sustainability commitments. Climate change is acknowledged as a risk. There are no quantified targets.
Cost programs. No formal program with targets, although cost containment is cited in the September 2025 Appendix 5B.
Medium-term financial targets and guidance. None issued. The FY2025 AR said the group "is dependent on the commencement of the royalty income stream commencing in the 2025/26 financial year." That did not happen in FY2026.
Products & Services
Macarthur has no commercial products or services. Its "portfolio" is a set of mineral assets and potential products. Each is catalogued below.
Moonshine Magnetite Concentrate (planned flagship product)
| Item | AUD Mn | USD Mn |
|---|---|---|
| Life-of-mine sales revenue | 12,614 | 8,956 |
| Life-of-mine operating expenses | 8,116 | 5,672 |
| Construction capex | 801.1 | 568.8 |
| Pre-strip | 61.6 | 43.8 |
| Total initial capital | 862.7 | 612.5 |
| Sustaining capital | 203.0 | 144.1 |
| Total future capital | 598.0 | 424.6 |
| Closure and rehabilitation | 58.2 | 41.3 |
| Total operating cash flow | 3,625 | 2,574 |
| Tax paid | 873 | 620 |
| Royalties | 631 | 435 |
| NPV (6%) pre-tax | 816 | 579 |
| NPV (6%) post-tax | 443 | 314 |
| IRR pre-tax | 13.0% | — |
| IRR post-tax | 10.1% | — |
Description: High-grade magnetite concentrate from the Moonshine and Moonshine North deposits, Lake Giles.
- Key specifications (2022 Feasibility Study, NI 43-101 filed 11 Apr 2022). Concentrate grade 66.1–66.2% Fe; SiO2 about 6.5%; Al2O3 about 0.1%; P about 0.02%; plant recovery 31% (DTR basis); throughput 3 Mtpa concentrate (dry); 74 Mt total concentrate over 25 years.
Reserves: 51.9 Mt Proven @ 30.6% Fe and 184.7 Mt Probable @ 27.6% Fe, totalling 236.6 Mt @ 28.2% Fe head grade, at a DTR cut-off above 15%.
Resources: 53.9 Mt Measured, 218.7 Mt Indicated and 997.0 Mt Inferred (Aug 2020).
Target customer: Seaborne steelmakers, blast-furnace pellet feed and DRI pathways.
Status: Feasibility complete; not financed; no offtake currently confirmed in 2025–26 filings. The 2019 Glencore agreement's status is not publicly disclosed.
Pricing model: Index-linked iron ore pricing, assumed in the Feasibility Study. Specific price assumptions are not restated in recent filings.
Feasibility Study economics (single-period, FY2022 study, A$ M unless stated):
Source: FY2025 AR, Table 1. Strip ratio 2.64; ore mined 236.6 Mt; waste 624.9 Mt.
Ularring Hematite (direct shipping ore) — now a royalty asset
Resource: 54.5 Mt @ 47.2% Fe Indicated and 26 Mt @ 45.4% Fe Inferred (CSA Global; NI 43-101 PFS, 2012).
Approvals: Environmental approvals under the WA Environmental Protection Act 1986 and the federal EPBC Act 1999. Program of Work approvals were received on 2 April 2026 (M30/249 and M30/213; clearing, access and ground disturbance) and announced 3 September 2026 (Central region hematite bulk sampling).
Commercial structure: Hematite mining rights over Ularring and Treppo Grande (excluding Moonshine) were sold to GVY in 2024. Consideration was A$750,000 cash (received in full by 17 Dec 2024), plus A$5M on the first 1 Mt dmt sold, A$5M on the second 1 Mt dmt, and A$1/dmt thereafter. Since 4 June 2026, GVY and Destec Contracting each hold 50% of the counterparty position.
Product intent: Bulk sampling to assess product quality, beneficiation response and blending with magnetite (Q1 FY2027 quarterly).
Treppo Grande / Mount Manning Iron Project
Area: 68 km² located 32 km west of Lake Giles, near rail to Esperance.
Status: E77/2521 refused on 16 Sep 2022. ELA 77/3186 (23 sub-blocks) has been under application since 22 Nov 2023 and is held by Esperance Iron Ore Export Company. It lies within the proposed Helena and Aurora Range National Park, which is a material permitting risk.
Lake Giles Nickel and Cobalt Targets
Evidence: 319 historical holes with ≥0.1% Ni and 150 holes with ≥0.2% Ni. Best intercept: LGDD_054, 23.5 m @ 0.85% Ni including 11.5 m @ 1.03% Ni. Gossanous grab samples assayed up to 2.61% Co and 2.01% Ni. Seven advanced targets remain untested (May 2023 release).
Status: Dormant. A non-iron-ore sampling program at Lake Giles returned initial results that were "inconclusive" (Jun-2026 quarterly).
Pilbara Iron-Ore Rights
Tenements: E45/4735 (Strelley Gorge, 5 sub-blocks, expires 20 Nov 2027) and E45/5324 (North Tambourah, 4 sub-blocks, expires 2029). Total area about 24 km².
Encumbrance: Infinity Mining holds non-iron-ore rights. Strelley Gorge borders the Sulphur Springs VHMS deposit owned by Develop Global.
Infrastructure Tenure (enabling assets)
-
Miscellaneous licences L30/71, L30/89 (23,663 ha, granted 11 Dec 2024), L30/92 (31,650 ha), L30/93, plus pending L15/409, L16/133, L30/90 and L30/91.
-
General-purpose leases G30/10–12 (pending).
-
E30/568 and E30/592 (3,277 ha, applied 25 Sep 2025).
-
Purpose: haul roads, borefields and water supply. These support any development route to the Perth–Kalgoorlie railway, about 90 km away.
Nevada Lithium
- Held through Macarthur Lithium Nevada Limited. No activity has been reported in FY2025–FY2026 quarterlies. Asset details are not publicly disclosed in recent filings.
Financial Narrative
All figures are in A$ millions unless stated, for fiscal years ending 31 March. FY2022–FY2025 come from the audited FY2025 AR (five-year summary and primary statements).
Income Statement
Notes: - The FY2022 profit reflects non-operating gains, not sales. TipRanks reports FY2022 net income as A$4.38M versus A$4.45M in the AR. The AR figure is used.
-
FY2026 EBITDA (-A$1.536M) is Kalkine's trailing-twelve-month figure.
-
FY2026 net loss (A$1,822,189) is from the FY2026 AR as summarised by FilingReader.
-
StockAnalysis reports FY2026 trailing-twelve-month EPS of about -A$0.01.
Margins and growth. Gross, operating, EBITDA and net margins are not meaningful: there is no sales revenue, so the denominators are zero or immaterial. Revenue CAGR is likewise not meaningful.
Commentary. The earnings record has three distinct regimes:
FY2022 profit: A paper profit driven by non-operating gains around the Infinity Mining spin-out.
FY2023–FY2024 cash-burn phase: Losses of A$4.9M and A$5.8M. These were inflated by share-based compensation (A$1.15M in FY2024) and equity-accounted losses and impairment on Infinity (A$2.42M combined in FY2024).
FY2025 capitulation: The hematite sale crystallised a A$21.99M accounting loss, because carrying value was written down to the A$750K cash consideration. The contingent A$10M+ royalties were not recognised as an asset.
FY2026 is the first "clean" year. The net loss of A$1.82M reflects a lean corporate structure: two employees, board-led management and minimal exploration. Even so, the loss remains large relative to cash on hand.
Balance Sheet
Notes: - FY2026 equity is derived as total assets (A$53.885M) less total liabilities (A$1.507M), both per Kalkine.
-
FY2025 cash was just A$784 at 31 March 2025. This confirms the acute liquidity position before the May 2025 convertible note and the July 2025 rights issue.
-
FY2023 cash and equity come from the opening balances in the FY2024 statements.
Commentary. The balance sheet is almost entirely capitalised exploration and evaluation expenditure. That balance stood at A$52.5M at FY2025, against total assets of A$52.9M. The A$22.8M fall in FY2025 reflects the hematite sale write-down. Equity has held near A$51–52M since then. With market capitalisation at roughly A$7M, the market prices the company at about 0.13–0.14x book. That is a deep discount, consistent with doubts about both recoverability and funding. Debt has been small and mostly owed to directors and a major shareholder: director loans totalled A$134K at FY2025.
Cash Flow
Commentary. The September 2025 quarter outflow of A$1.76M likely included settlement of accumulated creditors and accrued director fees after the rights issue. Payables had reached A$1.54M at FY2025. In the March 2026 quarter, net operating outflow was only A$118K, helped by A$102K of receipts, which suggests a much-reduced run-rate. Cash still fell from A$799K to A$324K in the June 2026 quarter. That implies a quarterly burn of roughly A$0.45M once placement costs and accrued items are included. On those figures, the company has funding into roughly late calendar 2026 without new capital, so another raise is likely within months. This is an analyst inference.
Ratios
Ratios are computed by the analyst from the reported figures above. Net debt to EBITDA and interest coverage are not meaningful because EBITDA is negative. The cash conversion cycle does not apply to a company with no inventory or sales.
Going concern. Auditors flagged a material uncertainty over going concern in both FY2025 (RSM) and FY2026, per FilingReader. At FY2025, current liabilities exceeded current assets by A$1.50M.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment and Revenue by Segment (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Exploration segment revenue and other income (AUD Mn) | 9.197 | 0.903 | 0.257 | 0.047 | 0.013 |
Exploration segment pre-tax result (AUD Mn) | 4.452 | -4.885 | -5.762 | -26.533 | -1.822 |
Share of total group revenue (%) | 100 | 100 | 100 | 100 | 100 |
Group Entities
| Entity | Ownership | Function |
|---|---|---|
Macarthur Minerals Limited | Parent; ASX-listed | Holding company |
Macarthur Australia Limited | 100% | Intermediate holding company |
Macarthur Iron Ore Pty Ltd ("MIO") | 100% (via Macarthur Australia) | Holds Lake Giles and Pilbara iron-ore tenements; counterparty to the Lake Giles Hematite Agreement |
Esperance Iron Ore Export Company Pty Ltd (formerly Macarthur Midway Pty Ltd) | 100% | Export logistics vehicle; applicant for E77/3186 (Mount Manning) |
Macarthur Lithium Nevada Limited | 100% | Nevada lithium exploration (inactive in current disclosures) |
Macarthur Marble Bar Lithium Pty Ltd (formerly Bachelor Project Pty Ltd) | 100% | Dormant |
Macarthur Minerals NT Pty Ltd and Macarthur Tulshyan Pty Ltd | 100% | Northern Territory vehicles (inactive) |
Asset group
| Asset group | Contents | Status (Oct 2026) |
|---|---|---|
Lake Giles – Moonshine Magnetite | Moonshine and Moonshine North deposits; 236.6 Mt Proven and Probable reserve | Feasibility Study complete (2022); seeking partner; no field work in recent quarters |
Lake Giles – Ularring Hematite (and Treppo Grande) | 54.5 Mt Indicated + 26 Mt Inferred hematite; environmentally approved | Mining rights sold to GVY (now GVY 50% / Destec 50%); Macarthur keeps title and royalties; bulk-sampling PoWs approved Apr and Sep 2026 |
Lake Giles – Nickel/Cobalt | Komatiite-hosted Ni targets; historical intercepts | Untested; non-iron sampling inconclusive |
Pilbara iron ore | E45/4735 (Strelley Gorge), E45/5324 (North Tambourah) | Iron-ore rights only; Infinity Mining holds non-iron rights |
Nevada lithium | Macarthur Lithium Nevada Ltd | Not mentioned in recent quarterly activities |
Income Statement and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue and other income (AUD Mn) | 9.197 | 0.903 | 0.259 | 0.047 | 0.013 |
Of which operating sales revenue (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Gross profit (AUD Mn) | — | — | — | — | 0.013 |
EBITDA (AUD Mn) | 4.489 | -4.793 | -5.627 | -26.435 | -1.536 |
EBIT / operating result (AUD Mn) | 4.457 | -4.866 | -5.698 | -26.474 | — |
Pre-tax income (AUD Mn) | 4.452 | -4.885 | -5.762 | -26.533 | -1.822 |
Net income (AUD Mn) | 4.452 | -4.885 | -5.762 | -26.533 | -1.822 |
Basic EPS (A$ cents) | 3.10 | -2.97 | -3.47 | -13.92 | — |
Diluted EPS (A$ cents) | 3.10 | -2.97 | -3.47 | -13.92 | — |
Dividends per share (A$ cents) | 0 | 0 | 0 | 0 | 0 |
Weighted average shares (M) | 147.93 | 164.64 | 166.06 | 190.60 | — |
Expense line
| Expense line | FY2024 | FY2025 |
|---|---|---|
Loss on sale of Hematite Project | 0 | 21,990,791 |
Personnel costs | 844,771 | 1,160,162 |
Professional fees | 661,298 | 944,051 |
Net fair value loss on financial assets | 0 | 773,368 |
Loss on disposal of financial assets | 0 | 454,972 |
Impairment of exploration and evaluation | 0 | 309,524 |
Share registry, filing and listing fees | 195,670 | 209,044 |
Share-based compensation | 1,149,201 | 190,729 |
Office and general | 294,423 | 152,879 |
Share of associate losses (Infinity) | 1,778,431 | 0 |
Impairment of investment in associate | 644,315 | 0 |
Investor relations | 277,421 | 33,898 |
Total expenses | 6,020,608 | 26,579,503 |
Balance Sheet
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (AUD Mn) | — | — | 77.690 | 52.888 | 53.885 |
Cash and equivalents (AUD Mn) | — | 1.944 | 0.181 | 0.001 | 0.796 |
Exploration and evaluation assets (AUD Mn) | — | — | 75.292 | 52.532 | — |
Total current assets (AUD Mn) | — | — | 0.418 | 0.293 | — |
Short-term borrowings (AUD Mn) | — | — | 0.838 | 0.244 | — |
Long-term borrowings (AUD Mn) | — | — | 0 | 0 | — |
Lease liabilities (AUD Mn) | — | — | 0.081 | 0 | — |
Total liabilities (AUD Mn) | — | — | 1.741 | 1.807 | 1.507 |
Net debt (AUD Mn) | — | — | 0.738 | 0.243 | — |
Total equity (AUD Mn) | — | 80.076 | 75.950 | 51.082 | 52.378 |
Goodwill and intangibles (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Working capital (AUD Mn) | — | — | -1.299 | -1.499 | — |
Issued capital (AUD Mn) | — | 128.198 | 128.615 | 130.089 | — |
Accumulated losses (AUD Mn) | — | -58.708 | -64.469 | -90.214 | — |
Cash Flow
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating cash flow (AUD Mn) | — | — | -1.745 | -1.331 | — |
Exploration and evaluation payments (AUD Mn) | — | — | -1.062 | -0.290 | — |
Property, plant and equipment capex (AUD Mn) | — | — | -0.001 | -0.019 | — |
Free cash flow incl. E&E (AUD Mn) | — | — | -2.808 | -1.640 | — |
Proceeds from asset sales (AUD Mn) | — | — | 0 | 1.139 | — |
Financing cash flow (AUD Mn) | — | — | 1.124 | 0.320 | — |
Dividends paid (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Buybacks (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Financial Analysis
| Metric | Q2 FY2026 (Sep-25) | Q4 FY2026 (Mar-26) | Q1 FY2027 (Jun-26) |
|---|---|---|---|
Net operating cash flow | -1.760 | -0.118 | — |
Net financing cash flow | 2.287 | 0.771 | — |
Closing cash | 0.315 | 0.799 | 0.324 |
Estimated quarters of funding | 0.18 | 6.77 | — |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
ROE on closing equity (%) | -6.1 | -7.6 | -51.9 | -3.5 |
ROA on closing assets (%) | — | -7.4 | -50.2 | -3.4 |
Current ratio (x) | — | 0.24 | 0.16 | — |
Debt to equity (x) | — | 0.011 | 0.005 | — |
Asset turnover (x) | — | 0.003 | 0.001 | 0.000 |
Revenue by Region
| Region | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Australia revenue and other income (AUD Mn) | 0.259 | 0.047 | 0.013 |
United States revenue (AUD Mn) | 0 | 0 | 0 |
Rest of world revenue (AUD Mn) | 0 | 0 | 0 |
Share Price
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|
Share price at fiscal year end (CAD, TSXV) | 0.51 | 0.47 | 0.15 | 0.09 | 0.03 | — |
Share price at or near fiscal year end (A$, ASX) | — | — | — | — | — | 0.026 |
Valuation Multiples
| Multiple | MIO | Comment |
|---|---|---|
P/B | about 0.14x | About A$7.1M market cap (Kalkine) against about A$52.4M equity (FY2026) |
EV per reserve tonne | about A$0.03/t | About A$7M EV against 236.6 Mt reserve (analyst-calculated) |
Share Price & Returns
| Date | Instrument | Size | Price (AUD) | Attaching securities |
|---|---|---|---|---|
Dec 2019 | ASX IPO | 20,032,952 shares / A$5.008M | 0.25 | — |
Apr 2022 | Placement | A$5.72M net | — | — |
Mar 2024 | Rights offering | A$580,760 | — | Options at A$0.28, expired 27 Sep 2025 |
Jul 2024 | Placement | 24,193,831 shares / A$1.282M | 0.053 | 12,096,915 options at A$0.10, expired 29 Jul 2026 |
May 2025 | Convertible notes | A$250K | Convert at 0.015 | — |
Jul 2025 | Renounceable rights issue (1-for-2) | About A$1.996M | 0.02 | 1 option per 2 shares, A$0.03, 2-year term |
Apr 2026 | Placement | 50,000,000 shares / A$1.25M | 0.025 | 25,000,000 options at A$0.05, expire 7 Oct 2027 |
Analyst Conclusions
Management guidance. None quantitative. Management's stated priorities are:
-
keeping Lake Giles tenure in good standing;
-
advancing bulk sampling with GVY and Destec;
-
assessing development, funding and strategic pathways for Moonshine; and
-
managing working capital carefully (Jun-2026 quarterly).
Consensus. There is no analyst coverage, so no consensus growth expectations exist.
Bull Case
-
Royalty asymmetry. If GVY and Destec move from bulk sampling to shipments of about 1 Mt, a A$5M payment would arrive at no cost to Macarthur. That is roughly 70% of the current market cap. A second A$5M follows at 2 Mt. Destec's arrival as both operator partner and shareholder improves the odds of execution compared with GVY alone.
-
Deep asset discount. The market values a 236.6 Mt reserve with a completed Feasibility Study (post-tax NPV6 A$443M in 2022 terms) at about A$7M, or about 0.14x book. Any credible strategic partner would revalue the equity materially.
-
Green-iron tailwind. High-grade (66% Fe), low-impurity concentrate fits DR and pellet feed, where premiums are widening. A director with Simandou experience makes a partnership narrative more credible than for typical juniors.
Bear Case
-
Funding death spiral. Cash was A$324K at June 2026, against roughly A$0.45M quarterly outflow, with going-concern qualifications two years running. Macarthur will likely need to raise money again soon at or below A$0.02, extending serial dilution of 50% or more per year.
-
Royalty slippage. The FY2025 AR expected royalties to start in FY2025/26. None have been reported. Activity has stayed at the PoW and sampling stage, and low-grade (about 45–47% Fe) in-situ hematite may not be economic without beneficiation.
-
Magnetite unfinanceable as specified. A 10.1% post-tax IRR, 31% recovery and A$863M initial capital (2022 dollars, before cost inflation) make the project marginal. Western Australian magnetite history makes lenders cautious, and new high-grade Simandou supply competes in the same premium niche.
Key Catalysts and Monitorables (next 12 months)
| Catalyst | Expected timing | Watch for |
|---|---|---|
| Bulk-sampling execution by GVY and Destec | Q4 2026–H1 2027 | On-ground start, tonnages, beneficiation results |
| Next capital raising | Near term (implied by cash) | Price, size, strategic participation by Destec, GVY or Copulos |
| Sep-2026 and Dec-2026 quarterlies and Appendix 5Bs | 31 Oct 2026; Jan 2027 | Cash runway, related-party payments |
| Half-year report to 30 Sep 2026 | Dec 2026 | Going-concern language |
| Magnetite strategic partner | Unscheduled | Any MOU or term sheet led by Nigel Jones |
| Board refresh | Unscheduled | Appointment of an independent director or chair |
| ELA 77/3186 decision; national park boundaries | Unscheduled | Treppo Grande viability |
| Tenure renewals | Ahead of 1 Jul 2028 expiries | M30/206, 207, 228, 229 |
| First hematite sale (royalty trigger) | Not before 2027 (analyst view) | A$5M milestone at 1 Mt dmt |
Concluding Analyst Verdict
Macarthur Minerals is no longer the iron ore developer its boilerplate describes. It is an option-holder with a near-empty treasury. Its economic value now rests on three things it does not control: whether a private operator group (Gold Valley Yilgarn and Destec) can commercialise low-grade Yilgarn hematite; whether a well-funded strategic party will back a marginal 3 Mtpa magnetite project; and whether equity markets will keep funding a corporate overhead of roughly A$1.5–2M a year.
The asset base is genuine. The company holds a 236.6 Mt reserve with a completed Feasibility Study, granted mining leases, environmental approvals, infrastructure licences and fresh Program of Work approvals. Book equity of about A$52M against a market value of about A$7M shows how heavily the market discounts both recoverability and execution. The 2024 hematite transaction was defensible from a liquidity standpoint, but it crystallised a A$22M write-down, and its royalty timetable has already slipped past the FY2025/26 window the board itself flagged.
Destec's arrival in 2026, as both a shareholder and a 50% holder of the hematite agreement, is the most constructive development in years. It brings operating capability that Macarthur lacks. Recent on-market director buying, though small, is consistent with that view.
Against this, governance is thin. The Chair and CEO roles are combined, there is no confirmed independent director, board meetings are infrequent, related-party loans recur, and an ASX disclosure query and an auditor resignation both landed in April 2026. Liquidity is the binding constraint. The June 2026 cash balance of A$324K points to another dilutive raise within months.
Verdict: a high-risk, binary, speculative exposure. Absent a royalty event or a named magnetite partner, the base case is further share-count expansion at depressed prices. Key evidence to watch: bulk-sampling execution and the terms of the next capital raising.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Role | Appointed | Background | Total remuneration |
|---|---|---|---|---|
Cameron McCall | Executive Chairman and CEO | Board 27 Apr 2015; CEO Sep 2022 | Over 40 years in financial services and commercial property; more than 18 years at Hartleys and Macquarie Bank in equity capital markets and broking; runs a corporate advisory business. Former Infinity Mining director (Feb 2018–Aug 2024). | FY2025: A$354,425 (A$300,000 salary + A$54,425 equity). FY2024: A$387,560. FY2023: A$740K per Simply Wall St. |
Alan (Spence) Phillips | Non-Executive Director; Audit and Risk Committee member | 19 Oct 2005 | 40 years as executive, director or chair of ASX, TSXV, TSX and AIM companies; start-ups and turnarounds in copper, gold, ethanol, iron ore and technology. Re-elected at the 2026 AGM. | FY2025: A$141,469 (A$95,000 fees + A$46,469 equity) |
Nigel Jones | Non-Executive Director | — | Former Managing Director of Rio Tinto's Simandou iron-ore project; engaged to pursue strategic transactions for the magnetite project | Not publicly disclosed in material reviewed |
Mima Wirakara | Company Secretary | — | 15 years in company secretarial and governance roles for ASX, TSX and POMSoX resource companies | — |
Ian McCall | CFO (per Kalkine). A TipRanks item refers to a one-off equity bonus of 656,757 shares to a "former CFO, Mr McCall". | — | Not disclosed; family relationship to the Chairman not confirmed in filings reviewed | — |
Earl Evans | Consultant (per Kalkine) | — | — | — |
“—” = not publicly disclosed.
Major Shareholders
| Holder | Shares | Options | Restricted share units (hurdle: A$0.20 for 20 days, expire 24 Jan 2027) |
|---|---|---|---|
C McCall | 3,665,821 direct + 14,000 indirect | 1,900,000 | 700,000 |
A Phillips | 3,414,268 indirect | 1,848,100 | 600,000 |
R Welker | 0 | 2,300,000 | 600,000 |
Major Shareholders — Copulos Group
| Holder | Stake | Source / date |
|---|---|---|
Copulos Group | 31,972,435 shares, 16.01% at the date of the Form 604 used by InvestSMART | Form 604, 29 Apr 2026. The percentage base appears to predate the 2026 placement; discrepancy noted. |
Directors (combined) | Low single-digit % | Appendix 3Y notices |
Competitive Landscape
Key Competitors
| Competitor | Segment / asset | Relative positioning vs Macarthur |
|---|---|---|
Mineral Resources (ASX: MIN) | Former Yilgarn hematite operations (Koolyanobbing hub, Esperance exports) | Major diversified miner; incumbent user of Esperance logistics |
Fenix Resources (ASX: FEX) | Mid-West hematite producer with integrated haulage and port | Proves the small-scale hematite model Macarthur outsourced to GVY |
Mount Gibson Iron (ASX: MGX) | Hematite producer (Koolan Island) | Producing; net cash; competes for buyers |
Grange Resources (ASX: GRR) | Tasmanian magnetite and pellet producer (Savage River) | The only established Australian magnetite pellet producer; benchmark for the magnetite model |
Magnetite Mines (ASX: MGT) | Razorback magnetite project, South Australia | Peer magnetite developer seeking strategic funding |
Hawsons Iron (ASX: HIO) | Hawsons magnetite project, NSW | Peer magnetite developer, also capital-constrained |
CZR Resources (ASX: CZR) | Robe Mesa hematite, Pilbara | Junior hematite developer |
Champion Iron (TSX/ASX: CIA) | High-grade concentrate producer, Quebec | Global high-grade/DR-grade competitor |
Cleveland-Cliffs / LKAB (global) | High-grade pellets and DR feed | Set the "green iron" quality benchmark |
Gold Valley group and other private Yilgarn operators | Small-scale DSO operators | Partner today, but also a competitor for tenure |
Peer Comparison FY2026
| Attribute | Macarthur (MIO) | Grange Resources | Magnetite Mines | Fenix Resources |
|---|---|---|---|---|
Stage | Feasibility (magnetite); royalty (hematite) | Producer | Pre-development | Producer |
Product grade | 66% Fe concentrate (study) | Pellets / concentrate | High-grade concentrate (study) | DSO hematite |
Initial capex need | A$863M | Sustaining only | — | Low |
Balance sheet | Cash A$0.3M (Jun 2026) | — | — | — |
Recent Developments
--



